$1.46
$0.08 (+6.18%)
$1.43Day Range$1.55
Key Statistics
Market Cap
$138.49M
Shares Outstanding
100.7M
Primary Exchange
XNAS
Currency
USD
Type
ADRC
IPO Date
Mar 25, 2015
Round Lot
100
Locale
US
Trading Data
Day Open
$1.45
Day High
$1.55
Day Low
$1.43
Volume
347.3K
VWAP
$1.50
Prev Close
$1.38
Transactions
--
Acc. Volume
--
About Cellectis S.A. American Depositary Shares
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
Identifiers
- CIK
- 0001627281
- Composite FIGI
- BBG0084L1XN2
- Share Class FIGI
- BBG0084L1YD1
- Ticker Root
- CLLS
About Cellectis S.A. American Depositary Shares (CLLS) Stock
Cellectis S.A. American Depositary Shares (CLLS) closed the 2026-09-17 session at $1.46, up 6.18% versus the previous close (+0.08). The stock opened at $1.45 and traded between $1.43 and $1.55 during that session. Session trading volume was 347K shares. The volume-weighted average price (VWAP) is $1.50.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
Cellectis S.A. American Depositary Shares has a market capitalization of $138.5 million. CLLS is listed on the XNAS exchange. The company employs approximately 229 people. The recorded listing date is 2015-03-25.
On this page you can find market CLLS stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors.